NAPROXEN SODIUM
-
naproxen sodium tablet, coated
Goldline Laboratories, Inc.
----------
NAPROXEN SODIUMPAIN RELIEVER / FEVER REDUCER (NSAID)
Drug Facts
Naproxen sodium 220 mg
(naproxen 200 mg) (NSAID)1
Pain reliever/fever reducer
Allergy alert: Naproxen sodium may cause a severe allergic reaction, especially in people allergic to aspirin. Symptoms may include:
If an allergic reaction occurs, stop use and seek medical help right away.
Stomach bleeding warning: This product contains a nonsteroidal anti-inflammatory drug (NSAID), which may cause stomach bleeding.
The chance is higher if you:
Do not use
Ask a doctor before use if you have
Ask a doctor or pharmacist before use if you are
When using this product
Stop use and ask a doctor if
If pregnant or breast-feeding, ask a health professional before use. It is especially important not to use naproxen sodium during the last 3 months of pregnancy unless definitely directed to do so by a doctor because it may cause problems in the unborn child or complications during delivery.
Keep out of reach of children. In case of overdose, get medical help or contact a Poison Control Center right away.
Adults and children 12 years and older |
|
Children under 12 years |
|
FD&C blue no. 2 aluminum lake, hypromellose, magnesium stearate, microcrystalline cellulose, polyethylene glycol, povidone, talc, titanium dioxide
call 1-888-838-2872, weekdays, 8 AM - 5 PM Eastern Time
***This product is not manufactured or distributed by Bayer HealthCare LLC, owner of the registered trademark Aleve®.
Dist. by: GOLDLINE LABORATORIES, INC.
Sellersville, PA 18960
Dist. 1996 0409REV 21
Goldline
TAMPER-EVIDENT
NDC 0182-1106-19
NAPROXEN
SODIUM
TABLETS USP, 220 mg
PAIN RELIEVER / FEVER REDUCER (NSAID)
STRENGTH TO LAST 12 HOURS
50 CAPLETS** (**CAPSULE-SHAPED TABLETS)
Goldline
KEEP CARTON FOR REFERENCE
NDC 0182-1106-19
TAMPER-EVIDENT
NAPROXEN
SODIUM
TABLETS USP, 220 mg
PAIN RELIEVER / FEVER REDUCER (NSAID)
ALL DAY RELIEF
STRENGTH TO LAST 12 HOURS
50 CAPLETS**
(**CAPSULE-SHAPED TABLETS)
ACTUAL SIZE
Compare to the active ingredient of Aleve®***
NAPROXEN SODIUM
naproxen sodium tablet, coated |
||||||||||||||||||||
|
||||||||||||||||||||
|
||||||||||||||||||||
|
||||||||||||||||||||
|
||||||||||||||||||||
|
Marketing Information | |||
Marketing Category | Application Number or Monograph Citation | Marketing Start Date | Marketing End Date |
ANDA | ANDA074661 | 05/15/2009 |
Labeler - Goldline Laboratories, Inc. (032349292) |